UAMY NYSE Primary Smelting & Refining Of Nonferrous Metals Financials FY2016βFY2025
United States Antimony Corp had $39.3M of revenue in fiscal 2025, up 162.8% on the year before. Over five years, revenue changed +49.6% a year on average.
Last close Β· Oct 23, 2026
$3.06
1.3%Hi! I read United States Antimony Corpβs latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Are sales growing?
+162.8%
Yes. Sales grew 162.8% last year.
Does it make a profit?
β11.1%
No. It lost money last year.
Does profit turn into cash?
β95.5%
No. It spent more cash than it brought in.
How healthy are the accounts?
4 / 9
Mixed. It passes 4 of 9 health tests.
How is the share priced?
β
No P/E: it made no profit over the last four quarters.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
KIRA Β· United States Antimony Corp had $39.3M of revenue in fiscal 2025, up 162.8% on the year before. Over five years, revenue changed +49.6% a year on average. Its operating margin was β21.5%, down 5.5Β pts: of every 100 in sales, about β22 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
Revenue
Margins, % of revenue
Margins, % of revenue
KIRA Β· United States Antimony Corp lost $4.3M in fiscal 2025.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
Net income
Diluted EPS
Diluted EPS
How much cash comes in, and where does it go?
KIRA Β· Free cash flow was β$37.5M in fiscal 2025, β95.5% of revenue.
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations vs capital spending
KIRA Β· United States Antimony Corp returned $0.4M to shareholders in fiscal 2025. The diluted share count rose 13.9%.
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
Dividends and buybacks
Diluted shares outstanding (annual)
KIRA Β· In the last 12 months, insiders bought $0.4M of shares on the open market and sold none.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.4M
5 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Joseph A CarrabbaDirector | Bought | 21,300 | $4.72 | $0.1M | Form 4 |
| Sep 1, 2026 | Lloyd BardswichDir, EVP & Chief Mining Eng, Director | Bought | 20,000 | $4.64 | $0.1M | Form 4 |
| Aug 31, 2026 | Blaise A. AguirreDirector | Bought | 1,400 | $5.04 | $0.0M | Form 4 |
| Aug 28, 2026 | Gary C EvansChairman & CEO, Director | Bought | 20,000 | $4.92 | $0.1M | Form 4 |
| Jun 15, 2026 | Jon R MarinelliDirector | Bought | 12,500 | $7.45 | $0.1M | Form 4 |
Can it carry its debts, and how well does it use its money?
KIRA Β· United States Antimony Corp has $30.3M more cash than debt.
Cash, debt and the ratios that show how comfortably United States Antimony Corp can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $21.4M | $19.1M | $18.1M | $18.2M | $30.5M |
| Debt incl. finance leases | $0.2M | $0.2M | $0.0M | $0.3M | $0.2M |
| Net debt / EBITDA | β95.9x | β15.0x | β | β | β |
| Debt / equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | β120.1x | 23.1x | β | β | β |
| Current ratio | 11.4x | 9.7x | 15.7x | 5.2x | 5.4x |
| Quick ratio | 10.9x | 9.1x | 14.1x | 4.9x | 4.1x |
| Total assets | $35.0M | $34.7M | $28.1M | $34.6M | $154M |
| Total liabilities | $2.6M | $2.8M | $2.6M | $6.0M | $13.0M |
| Shareholders' equity | $32.4M | $31.9M | $25.5M | $28.6M | $141M |
| Net debt (β = net cash) | β$21.2M | β$18.8M | β$18.1M | β$17.8M | β$30.3M |
KIRA Β· Its return on capital was β6.0%: every 100 invested in the business earned about β6 in a year.
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
KIRA Β· United States Antimony Corp passes 4 of 9 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 9 | 4 / 9 | 3 / 9 | 5 / 9 | 4 / 8 | 4 / 8 | 3 / 9 | 5 / 9 | 4 / 9 |
| Accruals ratio | β9.8% | β10.6% | 8.8% | β23.4% | β14.7% | 9.8% | 1.9% | β5.1% | β12.6% | 5.7% |
| Altman Z'' | β3.75 | β4.73 | β3.21 | β8.42 | β9.76 | 13.76 | 12.45 | 7.22 | 3.79 | 11.98 |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $11.9M | $10.2M | $9.0M | $8.3M | $5.2M | $7.7M | $11.0M | $8.7M | $14.9M | $39.3M |
| Provision for credit losses | β | β | β | β | β | β | β | β$0.2M | β$0.3M | β$0.0M |
| Gross profit | $0.5M | $0.3M | $0.0M | β$0.8M | $0.2M | $0.8M | $2.0M | β$3.3M | $3.5M | $9.9M |
| Operating income | β$0.8M | β$1.0M | $0.5M | β$3.8M | β$3.3M | β$0.7M | $0.3M | β$7.1M | β$2.4M | β$8.5M |
| Interest expense | $0.2M | $0.1M | $0.1M | $0.1M | $0.0M | $0.0M | $0.0M | β | β | β |
| Pretax income | β$1.0M | β$1.1M | $0.5M | β$3.7M | β$3.3M | β$0.1M | $0.4M | β$6.3M | β$1.7M | β$4.3M |
| Income tax | $0.3M | $0.0M | β$0.3M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Net income | β$1.3M | β$1.1M | $0.9M | β$3.7M | β$3.3M | β$0.1M | $0.4M | β$6.3M | β$1.7M | β$4.3M |
| Net income to common | β$1.4M | β$1.2M | $0.8M | β$3.7M | β$3.3M | β$0.1M | $0.4M | β$6.4M | β$1.7M | β$4.3M |
| Diluted EPS | β$0.02 | β$0.02 | $0.01 | β$0.05 | β$0.05 | β | β | β$0.06 | β$0.02 | β$0.04 |
| Diluted shares | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | β | 0.11B | 0.11B | 0.11B | 0.12B |
| Cash flow | ||||||||||
| Cash from operations | $0.4M | $0.7M | β$0.7M | β$0.0M | β$1.3M | β$2.4M | β$0.2M | β$4.8M | $2.2M | β$9.7M |
| Capital expenditure | $0.6M | $0.4M | $0.9M | $0.8M | $0.2M | $0.6M | $1.7M | $1.5M | $0.4M | $27.8M |
| Free cash flow | β$0.2M | $0.4M | β$1.6M | β$0.8M | β$1.5M | β$3.1M | β$2.0M | β$6.3M | $1.8M | β$37.5M |
| Depreciation and amortization | $1.0M | $1.0M | $0.9M | $0.9M | $0.9M | $0.9M | $0.9M | $1.0M | $1.1M | $1.2M |
| Stock-based compensation | $0.1M | $0.2M | $0.2M | $0.2M | $0.1M | $0.1M | β | $0.0M | $0.6M | $7.1M |
| Share buybacks | β | β | β | β | β | $0.0M | $0.2M | $0.0M | β | $0.4M |
| Dividends paid | β | β | β | β | β | β | $0.0M | $0.8M | $0.0M | β |
| Dividends and buybacks | β | β | β | β | β | $0.0M | $0.2M | $0.8M | $0.0M | $0.4M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $0.0M | $0.0M | $0.1M | $0.2M | $0.7M | $21.4M | $19.1M | $18.1M | $18.2M | $30.5M |
| Total debt | $1.9M | $1.8M | $1.7M | $0.1M | $0.1M | $0.2M | $0.2M | $0.0M | $0.3M | $0.2M |
| Current assets | $1.7M | $1.6M | $1.9M | $1.3M | $1.8M | $23.6M | $21.6M | $14.1M | $20.7M | $54.7M |
| Current liabilities | $3.4M | $3.9M | $3.5M | $4.0M | $4.5M | $2.1M | $2.2M | $0.9M | $4.0M | $10.2M |
| Inventory | $0.9M | $0.9M | $0.8M | $0.6M | $0.7M | $1.1M | $1.4M | $1.4M | $1.2M | $12.5M |
| Property and equipment, net | $15.7M | $15.1M | $15.2M | $12.2M | $11.2M | $11.1M | $12.1M | $13.5M | $12.9M | $42.4M |
| Total assets | $17.8M | $17.1M | $17.6M | $13.7M | $13.3M | $35.0M | $34.7M | $28.1M | $34.6M | $154M |
| Total liabilities | $6.4M | $6.8M | $6.1M | $5.2M | $6.1M | $2.6M | $2.8M | $2.6M | $6.0M | $13.0M |
| Preferred stock | $0.0M | $0.0M | $0.0M | β | β | β | β | β | β | β |
| Shareholders' equity | $11.3M | $10.4M | $11.4M | $8.5M | $7.2M | $32.4M | $31.9M | $25.5M | $28.6M | $141M |
| Margins | ||||||||||
| Gross margin | 4.5% | 2.7% | 0.0% | β9.9% | 3.9% | 10.8% | 18.1% | β38.5% | 23.2% | 25.2% |
| Operating margin | β6.9% | β9.4% | 6.1% | β45.4% | β63.1% | β8.5% | 3.2% | β81.3% | β16.0% | β21.5% |
| EBITDA margin | 1.5% | 0.1% | 16.1% | β34.6% | β46.2% | 2.8% | 11.4% | β70.3% | β8.7% | β18.6% |
| Net margin | β11.0% | β11.1% | 9.7% | β44.4% | β62.8% | β0.8% | 3.9% | β73.0% | β11.6% | β11.1% |
| FCF margin | β1.4% | 3.4% | β17.2% | β9.7% | β29.6% | β39.7% | β17.9% | β72.2% | 12.0% | β95.5% |
| Returns | ||||||||||
| Return on capital | β4.9% | β6.2% | 4.2% | β35.2% | β39.9% | β4.7% | 2.6% | β75.1% | β17.6% | β6.0% |
| Return on capital employed | β5.7% | β7.3% | 3.9% | β38.6% | β37.5% | β2.0% | 1.1% | β26.0% | β7.8% | β5.9% |
| Return on equity | β11.5% | β10.4% | 8.0% | β36.9% | β42.0% | β0.3% | 1.3% | β22.1% | β6.4% | β5.1% |
| Return on assets | β7.4% | β6.5% | 5.0% | β23.5% | β24.4% | β0.3% | 1.2% | β20.2% | β5.5% | β4.6% |
| Return on tangible equity | β12.0% | β11.4% | 7.2% | β44.0% | β46.4% | β0.3% | 1.2% | β24.9% | β6.1% | β3.1% |
| Growth | ||||||||||
| Revenue growth | β | β14.0% | β11.7% | β8.5% | β36.7% | 48.0% | 42.6% | β21.3% | 71.8% | 162.8% |
| Net income growth | β | β | β | β520.6% | β | β | β | β1,580.8% | β | β |
| EPS growth | β | β | β | β600.0% | β | β | β | β | β | β |
| FCF growth | β | β | β542.8% | β | β | β | β | β | β | β2,195.3% |
| Share count change | β | 0.9% | 1.0% | 1.3% | 5.1% | β | β | 1.2% | 1.0% | 13.9% |
| Financial health | ||||||||||
| Net debt / EBITDA | 10.1x | 191.1x | 1.2x | β | β | β95.9x | β15.0x | β | β | β |
| Debt / equity | 0.2x | 0.2x | 0.2x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | β5.1x | β9.0x | 5.5x | β47.9x | β183.6x | β120.1x | 23.1x | β | β | β |
| Current ratio | 0.5x | 0.4x | 0.5x | 0.3x | 0.4x | 11.4x | 9.7x | 15.7x | 5.2x | 5.4x |
| Quick ratio | 0.2x | 0.2x | 0.3x | 0.2x | 0.3x | 10.9x | 9.1x | 14.1x | 4.9x | 4.1x |
| Capital allocation | ||||||||||
| Capex / revenue | 5.0% | 3.6% | 10.0% | 9.6% | 4.6% | 8.4% | 15.6% | 17.6% | 2.9% | 70.8% |
| Stock comp / revenue | 1.2% | 1.7% | 1.9% | 2.1% | 2.5% | 1.4% | β | 0.0% | 3.8% | 18.0% |
| Payouts / FCF | β | β | β | β | β | β | β | β | 0.0% | β |
| Quality scores | ||||||||||
| Piotroski F-score | β | 4.0 | 4.0 | 3.0 | 5.0 | 4.0 | 4.0 | 3.0 | 5.0 | 4.0 |
| Altman Z'' | β3.7 | β4.7 | β3.2 | β8.4 | β9.8 | 13.8 | 12.4 | 7.2 | 3.8 | 12.0 |
| Accruals ratio | β9.8% | β10.6% | 8.8% | β23.4% | β14.7% | 9.8% | 1.9% | β5.1% | β12.6% | 5.7% |
Source: SEC EDGAR XBRL filings (CIK 0000101538). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
